These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 15562293)

  • 21. The activity of pramipexole in the mouse forced swim test is mediated by D2 rather than D3 receptors.
    Siuciak JA; Fujiwara RA
    Psychopharmacology (Berl); 2004 Sep; 175(2):163-9. PubMed ID: 14985923
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of the D(3) dopamine receptor antagonist, U99194A, on brain stimulation and d-amphetamine reward, motor activity, and c-fos expression in ad libitum fed and food-restricted rats.
    Carr KD; Yamamoto N; Omura M; Cabeza de Vaca S; Krahne L
    Psychopharmacology (Berl); 2002 Aug; 163(1):76-84. PubMed ID: 12185403
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dopamine D3 as well as D2 receptor ligands attenuate the cue-induced cocaine-seeking in a relapse model in rats.
    Gál K; Gyertyán I
    Drug Alcohol Depend; 2006 Jan; 81(1):63-70. PubMed ID: 16005579
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CB1 receptor knockout mice display reduced ethanol-induced conditioned place preference and increased striatal dopamine D2 receptors.
    Houchi H; Babovic D; Pierrefiche O; Ledent C; Daoust M; Naassila M
    Neuropsychopharmacology; 2005 Feb; 30(2):339-49. PubMed ID: 15383833
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Acquisition of nicotine discrimination and discriminative stimulus effects of nicotine in rats chronically exposed to caffeine.
    Gasior M; Shoaib M; Yasar S; Jaszyna M; Goldberg SR
    J Pharmacol Exp Ther; 1999 Mar; 288(3):1053-73. PubMed ID: 10027843
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reevaluation of PNU-99194A discriminative stimulus effects: potentiation by both a D2 antagonist and a D3/D2 agonist.
    Baker LE; Prus AJ
    Pharmacol Biochem Behav; 2002 Nov; 73(4):753-8. PubMed ID: 12213519
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dopamine D3 receptor agonists partially reproduce the discriminative stimulus effects of cocaine in squirrel monkeys.
    Spealman RD
    J Pharmacol Exp Ther; 1996 Sep; 278(3):1128-37. PubMed ID: 8819495
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dopamine D1- and D2-like receptor mechanisms in relapse to cocaine-seeking behavior: effects of selective antagonists and agonists.
    Khroyan TV; Barrett-Larimore RL; Rowlett JK; Spealman RD
    J Pharmacol Exp Ther; 2000 Aug; 294(2):680-7. PubMed ID: 10900248
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dopamine D1/5 and D2/3 agonists differentially attenuate somatic signs of nicotine withdrawal in rats.
    Ohmura Y; Jutkiewicz EM; Zhang A; Domino EF
    Pharmacol Biochem Behav; 2011 Oct; 99(4):552-6. PubMed ID: 21624384
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evidence for dopamine D(1) receptor involvement in the stimulus selection task: overshadowing in the rat.
    O'Tuathaigh CM; Moran PM
    Psychopharmacology (Berl); 2002 Jul; 162(3):225-31. PubMed ID: 12122479
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Assessment of the discriminative stimulus effects of the D3 dopamine antagonist PNU-99194A in rats: comparison with psychomotor stimulants.
    Baker LE; Miller ME; Svensson KA
    Behav Pharmacol; 1997 Jun; 8(2-3):243-52. PubMed ID: 9833019
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The D3R partial agonist, BP 897, attenuates the discriminative stimulus effects of cocaine and D-amphetamine and is not self-administered.
    Beardsley PM; Sokoloff P; Balster RL; Schwartz JC
    Behav Pharmacol; 2001 Feb; 12(1):1-11. PubMed ID: 11270507
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Targeting the dopamine D3 receptor: an overview of drug design strategies.
    Cortés A; Moreno E; Rodríguez-Ruiz M; Canela EI; Casadó V
    Expert Opin Drug Discov; 2016 Jul; 11(7):641-64. PubMed ID: 27135354
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dopamine is involved in the antidepressant-like effect of allopregnanolone in the forced swimming test in female rats.
    D'Aquila PS; Canu S; Sardella M; Spanu C; Serra G; Franconi F
    Behav Pharmacol; 2010 Feb; 21(1):21-8. PubMed ID: 20009921
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Motivational properties of D2 and D3 dopamine receptors agonists and cocaine, but not with D1 dopamine receptors agonist and L-dopa, in bilateral 6-OHDA-lesioned rat.
    Zengin-Toktas Y; Authier N; Denizot H; Chassain C; Hafidi A; Llorca PM; Durif F
    Neuropharmacology; 2013 Jul; 70():74-82. PubMed ID: 23347953
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antidepressant-like effect of D(2/3) receptor-, but not D(4) receptor-activation in the rat forced swim test.
    Basso AM; Gallagher KB; Bratcher NA; Brioni JD; Moreland RB; Hsieh GC; Drescher K; Fox GB; Decker MW; Rueter LE
    Neuropsychopharmacology; 2005 Jul; 30(7):1257-68. PubMed ID: 15688083
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Does combined treatment with novel antidepressants and a dopamine D3 receptor agonist reproduce cocaine discrimination in rats?
    Filip M; Papla I
    Pol J Pharmacol; 2001; 53(6):577-85. PubMed ID: 11985331
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dopamine D3/D2 Receptor Antagonist PF-4363467 Attenuates Opioid Drug-Seeking Behavior without Concomitant D2 Side Effects.
    Wager TT; Chappie T; Horton D; Chandrasekaran RY; Samas B; Dunn-Sims ER; Hsu C; Nawreen N; Vanase-Frawley MA; O'Connor RE; Schmidt CJ; Dlugolenski K; Stratman NC; Majchrzak MJ; Kormos BL; Nguyen DP; Sawant-Basak A; Mead AN
    ACS Chem Neurosci; 2017 Jan; 8(1):165-177. PubMed ID: 27715007
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dopamine D3 receptor ligands for the treatment of tobacco dependence.
    Le Foll B; Goldberg SR; Sokoloff P
    Expert Opin Investig Drugs; 2007 Jan; 16(1):45-57. PubMed ID: 17155853
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A dopamine D3 receptor partial agonist blocks the expression of conditioned activity.
    Aujla H; Sokoloff P; Beninger RJ
    Neuroreport; 2002 Jan; 13(1):173-6. PubMed ID: 11924883
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.